CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Chong Kun Dang Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 7, 2024Injectable Long-Acting Naltrexone Microparticle Compositions1

Top competitors of Chong Kun Dang Pharmaceutical

Top competitors of Chong Kun Dang Pharmaceutical based on patent oppositions.